RENGA, Barbara
 Distribuzione geografica
Continente #
NA - Nord America 2.867
EU - Europa 2.187
AS - Asia 1.240
SA - Sud America 253
AF - Africa 22
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 2
Totale 6.574
Nazione #
US - Stati Uniti d'America 2.827
IE - Irlanda 486
SG - Singapore 481
UA - Ucraina 374
HK - Hong Kong 335
RU - Federazione Russa 266
SE - Svezia 258
IT - Italia 253
BR - Brasile 235
VN - Vietnam 158
FI - Finlandia 153
DE - Germania 133
CN - Cina 122
FR - Francia 62
TR - Turchia 53
GB - Regno Unito 47
EE - Estonia 36
KR - Corea 27
CA - Canada 23
CH - Svizzera 22
CZ - Repubblica Ceca 16
IN - India 16
PL - Polonia 14
RO - Romania 13
AT - Austria 12
BE - Belgio 12
NL - Olanda 12
MX - Messico 10
ZA - Sudafrica 9
BD - Bangladesh 8
GR - Grecia 8
ES - Italia 7
LB - Libano 6
UZ - Uzbekistan 6
AE - Emirati Arabi Uniti 5
EC - Ecuador 5
KE - Kenya 5
AR - Argentina 4
PK - Pakistan 4
VE - Venezuela 4
AU - Australia 3
CO - Colombia 3
IQ - Iraq 3
KG - Kirghizistan 3
MA - Marocco 3
BN - Brunei Darussalam 2
DZ - Algeria 2
EG - Egitto 2
EU - Europa 2
HN - Honduras 2
JO - Giordania 2
JP - Giappone 2
KZ - Kazakistan 2
PA - Panama 2
AZ - Azerbaigian 1
BB - Barbados 1
CL - Cile 1
CR - Costa Rica 1
CY - Cipro 1
DO - Repubblica Dominicana 1
HU - Ungheria 1
IL - Israele 1
NO - Norvegia 1
NP - Nepal 1
PE - Perù 1
PT - Portogallo 1
SN - Senegal 1
TM - Turkmenistan 1
Totale 6.574
Città #
Chandler 552
Dublin 485
Hong Kong 335
Singapore 329
San Mateo 254
Jacksonville 167
Boardman 160
Dong Ket 156
Altamura 140
Santa Clara 132
Medford 119
Princeton 119
Lawrence 102
Andover 98
Wilmington 97
Ann Arbor 86
Moscow 78
Perugia 57
Beijing 49
Ashburn 43
Des Moines 42
Izmir 42
Columbus 41
Saint Petersburg 37
Helsinki 30
Munich 23
Los Angeles 22
New York 20
Falls Church 16
Norwalk 16
Seoul 16
Rio de Janeiro 14
São Paulo 14
San Paolo di Civitate 13
Timisoara 13
Woodbridge 13
Dearborn 12
Olomouc 12
Ottawa 12
Brussels 11
Turku 9
Belo Horizonte 7
Shanghai 7
The Dalles 7
Auburn Hills 6
Boston 6
Dallas 6
London 6
Phoenix 6
Salvador 6
Vienna 6
Campinas 5
Curitiba 5
Den Haag 5
Lausanne 5
Nairobi 5
Nuremberg 5
Toronto 5
Warsaw 5
Al Ain City 4
Atlanta 4
Charlotte 4
Chennai 4
Dhaka 4
Houston 4
Redwood City 4
San Francisco 4
Stockholm 4
Americana 3
Angri 3
Bishkek 3
Brasília 3
Brooklyn 3
Buffalo 3
Chicago 3
Frankfurt Am Main 3
Guarujá 3
Guarulhos 3
Juiz de Fora 3
Montreal 3
Philadelphia 3
Quito 3
San Diego 3
Seattle 3
Simi Valley 3
Sydney 3
Tashkent 3
Amman 2
Amsterdam 2
Ankara 2
Antakya 2
Araguaína 2
Athens 2
Bandar Seri Begawan 2
Barra Mansa 2
Campo Grande 2
Cape Town 2
Casablanca 2
Contagem 2
Cuiabá 2
Totale 4.208
Nome #
Leflunomide protects against dyslipidemia development induced by ritonavir in mice 105
Activation of the farnesoid-X receptor protects against gastrointestinal injury caused by non-steroidal anti-inflammatory drugs in mice. 101
BAR502, a Dual FXR and GPBAR1 Agonist, Reverses Steatosis and Fibrosis in Rodent Model of NASH By Modulating Authophagic Genes 98
Activation of the bile acid receptor GPBAR1 protects against gastrointestinal injury caused by non-steroidal anti-inflammatory drugs and aspirin in mice. 97
Efficacy of the CCR5 antagonist maraviroc in reducing early, ritonavir-induced atherogenesis and advanced plaque progression in mice. 92
Bile-acid-activated farnesoid X receptor regulates hydrogen sulfide production and hepatic microcirculation. 91
A nitro-arginine derivative of trimebutine (NO2-Arg-Trim) attenuates pain induced by colorectal distension in conscious rats. 88
BAR 501, a Novel GPBAR1 Ligand, Reverses Intestinal and Liver Inflammatory Models Demonstrating That GPBAR1 Is an Essential Modulator of Innate Immunity in Entero-Hepatic Tissues 87
3alpha-6alpha-Dihydroxy-7alpha-fluoro-5beta-cholanoate (UPF-680), physicochemical and physiological properties of a new fluorinated bile acid that prevents 17alpha-ethynyl-estradiol-induced cholestasis in rats.. 84
Antiatherosclerotic effect of farnesoid X receptor. 81
Activation of FXR Improves Myocardial Fatty Acid Metabolism in a Rodent Model of Liver Steatosis 81
A Comprehensive Analysis of Small Heterodimer Partner (SHP) Target Genes in Hepatic Stellate Cells and the Discovery of a New Class of SHP Agonists That Reduces Liver Fibrosis 81
5-Amino-2-hydroxybenzoic acid 4-(5-thioxo-5H-[1,2]dithiol-3yl)-phenyl ester (ATB-429), a hydrogen sulfide-releasing derivative of mesalamine, exerts antinociceptive effects in a model of postinflammatory hypersensitivity. 80
Preliminary structure-activity relationship on theonellasterol, a new chemotype of FXR antagonist, from the marine sponge Theonella swinhoei. 79
An essential role of Farnesoid X-Receptor in regulating intestinal fibrosis in murine model of chronic colitis 78
Reciprocal regulation of the bile acid-activated receptor FXR and the interferon-gamma-STAT-1 pathway in macrophages. 76
Counter-regulatory role of bile acid activated receptors in immunity andinflammation. 75
Administration of 3 alpha-6 alpha-dihydroxy-7a alpha-fluoro-5 beta-cholanoate (UPF-680) in chronic cholestasis induced by 17 alpha-ethynyl-estradiol (17 alpha EE) in rats. 75
Interactions Between Nuclear Receptor SHP and FOXA1 Maintain Oscillatory Homocysteine Homeostasis in Mice 75
Glucocorticoid receptor mediates the gluconeogenic activity of the farnesoid X receptor in the fasting condition 74
Dissociation of intestinal and hepatic activities of FXR and LXRα supports metabolic effects of terminal ileum interposition in rodents. 72
Design, synthesis, and biological evaluation of potent dual agonists of nuclear and membrane bile acid receptors. 72
4-Methylenesterols from Theonella swinhoei sponge are natural pregnane-X-receptor agonists and farnesoid-X-receptor antagonists that modulate innate immunity. 71
a Farnesoid-X-Receptor (FXR)-Glucocorticoid Receptor (GR) Cascade Regulates Intestinal Innate Immunity in Response to FXR Activation 71
Epigenetic Modulation of Adhesion and Proliferation Pathways by Methionine Deficiency Attenuates Potential for Dissemination of Gastric Cancer Cells 70
Conicasterol E, a Small Heterodimer PartnerSparing Farnesoid X Receptor Modulator Endowed with a Pregnane X ReceptorAgonistic Activity, from the Marine Sponge Theonella swinhoei 69
Development of non-antibiotic macrolide that corrects inflammation-driven immune dysfunction in models of inflammatorybowel diseases and arthritis 69
3-oxa-lipoxin A4 analog treats colitis induced by Dss by attenuating inflammation and immunity. 69
Cardiac safety and antitumoral activity of a new nitric oxide derivative of pegylated epirubicin in mice. 66
The plant sterol guggulsterone attenuates inflammation and immune dysfunction in murine models of inflammatory bowel disease. 66
Ritonavir-induced lipoatrophy and dyslipidaemia is reversed by the anti-inflammatory drug leflunomide in a PPAR-γ-dependent manner. 66
Genetic Ablation and Pharmacological Blockade of CCR5 by the anti-HIV Small Molecule Inhibitor Maraviroc Inhibits Leukocyte Trafficking and Protects Against Mucosal Inflammation in Murine Models Colitis 66
The HIV Matrix Protein p17 subverts Nuclear Receptors Expression and induces a STAT1-Dependent Proinflammatory Phenotype in Monocytes 65
Discovery of sulfated sterols from marine invertebrates as a new class of marine naturalantagonists of farnesoid-X-receptor. 64
Discovery that theonellasterol a marine sponge sterol is a highly selective FXR antagonist that protects against liver injury in cholestasis. 64
The bile acid sensor farnesoid X receptor is a modulator of liver immunity in a rodent model of acute hepatitis. 63
Probiotics modulate intestinal expression of nuclear receptor and provide counter-regulatory signals to inflammation-driven adipose tissue activation. 63
Bile acid activated receptors are targets for regulation of integrity of gastrointestinal mucosa 63
The bile acid sensor FXR protects against dyslipidemia and aortic plaques development induced by the HIV protease inhibitor ritonavir in mice. 62
Farnesoid X receptor suppresses constitutive androstane receptoractivity at the multidrug resistance protein-4 promoter. 62
Modification in the side chain of solomonsterol A: discovery of cholestan disulfate as a potent pregnane-X-receptor agonist 62
Role of the FXR in Regulating Bile Acid Homeostasis and Relevance for Human Diseases 61
Evidence that hydrogen sulfide exerts antinociceptive effects in the gastrointestinal tract by activating KATP channels. 61
FXR mediates a chromatin looping in the GR promoter thus promoting the resolution of colitis in rodents. 61
Critical role of toll-like receptors in modulating GM-CSF activity in rodent models of colitis 60
Il valore predittivo del polimorfismo C-1237T del toll-like receptor 9 nell’eruzione eritemato-papulo-pustolosa da inibitori del fattore di crescita epidermico 59
Inhibition of NF-κB by a PXR-dependent pathwaymediates counter-regulatory activities of rifaximin on innate immunity inintestinal epithelial cells. 59
FXR activation improves myocardial fatty acid metabolism in a rodent model of obesity-driven cardiotoxicity. 59
The nuclear receptor FXR regulates hepatic transport and metabolism of glutamine and glutamate 58
Structural insights into Estrogen Related Receptor-β modulation: 4-methylenesterols from Theonella swinhoei sponge as the first example of marine natural antagonists. 58
The HIV Matrix Protein p17 promotes the Activation of human hepatic stellate cells through interactions with CXCR2 and Syndecan-2 57
Binding mechanism of the farnesoid X receptor marine antagonist suvanine reveals a strategy to forestall drug modulation on nuclear receptors. Design, synthesis, and biological evaluation of novel ligands. 57
Nitric oxide (NO)-releasing naproxen (HCT-3012) interactions with aspirin in gastric mucosa of arthritic rats reveals a role for aspirin-triggered lipoxin, prostaglandins and NO in gastric protection. 56
The third gas: H2S regulates perfusion pressure in both theisolated and perfused normal rat liver and in cirrhosis. 56
Exploitation of cholane scaffold for the discovery of potent and selective farnesoid X receptor (FXR) and G-protein coupled bile acid receptor 1 (GP-BAR1) ligands 56
The methyl trasnferase PRMT1 functions as coactivator of FXR/RXR and regulates transcription of FXR responsive genein hepatocytes 55
Gene Expression Changes Induced by HIPEC in a Murine Model of Gastric Cancer 55
Epigenetic modulation by methionine deficiency attenuates the potential for gastric cancer cell dissemination. 55
The methyl transferase PRMT1 functions as co-activator of farnesoid X receptor (FXR)/9-cis retinoid X receptor and regulates transcription of FXR responsive genes. 54
Cystathionine gamma-lyase, a H2S-generating enzyme, is a GPBAR1-regulated gene and contributes to vasodilation caused by secondary bile acids 54
A Novel Source of Intestinal Damage: The HIV Protease Inhibitor Ritonavir Worsens Damage Caused by COX Inhibitors 54
The bile acid receptor GPBAR-1 (TGR5) modulates integrity of intestinal barrier and immune response to experimental colitis. 54
Cross-talk between farnesoid-X-receptor (FXR) and peroxisome proliferator-activated receptor gamma contributes to the antifibrotic activity of FXR ligands in rodent models of liver cirrhosis. 53
Nitric oxide modulates proapoptotic and antiapoptotic properties of chemotherapy agents: the case of NO-pegylated epirubicin. 52
In vivo administration of ritonavir worsens intestinal damage caused by cyclooxygease inhibitors. 52
Impaired Itching Perception in Murine Models of Cholestasis Is Supported by Dysregulation of GPBAR1 Signaling 52
Hydrogen sulphide induces micro opioid receptor-dependent analgesia in a rodent model of visceral pain. 51
Polyhydroxylated sterols from the Indonesian softcoral Sinularia sp. and their effect on farnesoid X-activated receptor. 51
CCR5 Antagonism by Maraviroc Reduces the Potential for Gastric Cancer Cell Dissemination. 51
Insights on pregnane-X-receptor modulation. Natural and semisynthetic steroids from Theonella marine sponges. 51
SHP-dependent and -independent induction of peroxisomeproliferator-activated receptor-γ by the bile acid sensor farnesoid X receptorcounter-regulates the pro-inflammatory phenotype of liver myofibroblasts. 50
The methionine connection: homocysteine and hydrogen sulfide exert opposite effects on hepatic microcirculation in rats. 50
Pregnane-X-receptor mediates the anti-inflammatoryactivities of rifaximin on detoxification pathways in intestinal epithelialcells. 50
Inhibition of hydrogen sulfide generation contributes to gastric injury caused byanti-inflammatory nonsteroidal drugs. 49
Farnesoid-X-receptor (FXR) ligands induce a small heterodimer partner (SHP)-dependent upregulation of PPAR-gamma in hepatic stellate cells and in rat model of liver fibrosis. 49
H2S Induces Analgesia Is Mediated In Vivo Activation of mu Opioid Receptor and PI3K/AKT Pathway Activation 49
The CCR5 Antagonist Maraviroc Reduces the Potential for Gastric Cancer Dissemination in Rodent Models of Peritoneal Metastasis 49
The bile acid receptor FXR is a modulator of intestinal innate immunity. 49
Instruction of Intestinal Microbiota by VSL#3 Reverses NASH and Accelerated Atherosclerosis Caused by Intestinal Inflammation in ApoE(-/-) Mice 48
Il valore predittivo del polimorfismo C1237-T di TLR9 mutato nell’eruzione eritemato-papulo-pustolosa da inibitori dei recettori del fattore di crescita epidermico 47
Theonellasterols and conicasterols fromTheonella swinhoei. Novel marine natural ligands for human nuclear receptors. 46
The Bile Acid Sensor FXR Induces the Glucocorticoid Receptor in the Liver in a Promoter-Dependent Manner 46
Protective effects of granulocyte macrophage colony stimulating factor (gm-Csf) in Hapten-induced colitis 46
Co-administration of nitric oxide-aspirin (NCX-4016) andaspirin prevents platelet and monocyte activation and protects against gastric damage induced by aspirin in humans. 45
Reversal of Endothelial Dysfunction by GPBAR1 Agonism in Portal Hypertension Involves a AKT/FOXOA1 Dependent Regulation of H2S Generation and Endothelin-1 45
Essential Role of DNAX Adaptor Protein 12 (DAP12) and Spleen Tyrosine Kinase (Syk) in Inflammation-Driven Immune Dysfunction in Rodent Model of Colitis 44
Molecular Determinants of Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in a Model of Peritoneal Gastric Cancer Carcinogenesis 44
Solomonsterol A, a marine pregnane-X-receptor agonist, attenuates inflammation and immune dysfunction in a mouse model of arthritis. 44
Isoswinholide B and swinholide K, potently cytotoxic dimeric macrolides from Theonella swinhoei. 44
Total synthesis and pharmacological characterization of solomonsterol A, a potent marine pregnane-X-receptor agonist endowed with anti-inflammatory activity. 43
Role of Nuclear Receptors in Lipid Dysfunction and Obesity-related Diseases. 43
Quantitative NMR-Derived Interproton Distances Combined with QuantumMechanical Calculations of (13)C Chemical Shifts in the StereochemicalDetermination of Conicasterol F, a Nuclear Receptor Ligand from Theonellaswinhoei. 43
Solomonsterols A and B from Theonella swinhoei. The First Example of C-24 and C-23 Sulfated Sterols from a Marine Source Endowed with a PXR Agonistic Activity. 41
Role of Maraviroc in a dyslipidemic murine model of atherosclerosis RTV-induced 41
‘The Farnesoid X Receptor Promotes Adipocyte Differentiationd regulates adipose cell function in vivo’ 40
The Nuclear Receptor SHP Mediates Inhibition of Hepatic Stellate Cells by FXR and Protects Against Liver Fibrosis 40
Reciprocal Regulation of TLRS and Nuclear Receptors: IRF-7 Dependent Regulation of FXR Mediates Counter-Regulatory Effects of TLR-9 in Colitis 40
New tridecapeptides of the theonellapeptolide family from the Indonesian sponge Theonella swinhoei. 40
Probiotics VSL#3 protect against development of visceral pain in murine model of irritable bowel syndrome. 40
The HIV matrix protein p17 induces hepatic lipid accumulation via modulation of nuclear receptor transcriptoma 40
Totale 6.050
Categoria #
all - tutte 33.740
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 33.740


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021917 4 69 43 83 281 47 51 3 72 27 62 175
2021/2022898 14 167 9 48 31 10 10 342 6 13 92 156
2022/20231.798 129 344 11 175 135 188 0 89 662 2 47 16
2023/2024600 42 78 46 6 4 4 140 26 36 20 126 72
2024/20251.651 17 144 61 46 250 56 34 111 336 106 280 210
2025/202697 97 0 0 0 0 0 0 0 0 0 0 0
Totale 6.750